Oximes for acute organophosphate pesticide poisoning (Cochrane review) (2011)

Peer-Reviewed Study · Buckley NA, Eddleston M, Li Y, Bevan M, Robertson J · February 16, 2011

Buckley NA et al., 2011-02-16: Cochrane review confirming that oximes such as pralidoxime are given specifically to reactivate inhibited acetylcholinesterase, while finding the clinical benefit of oximes uncertain.

Standard treatment involves administration of intravenous atropine and oxime to reactivate inhibited acetylcholinesterase.

Abstract (Background)

Buckley NA et al., 2011-02-16: Cochrane review confirming that oximes such as pralidoxime are given specifically to reactivate inhibited acetylcholinesterase, while finding the clinical benefit of oximes uncertain. PMID 21328273, DOI 10.1002/14651858.CD005085.pub2, PMCID PMC13634667. Systematic review of RCTs. Supports the mechanistic half of the source's claim (oximes reactivate the enzyme) and contradicts the assertion that pralidoxime does not restore enzyme function; the review's uncertainty is about clinical outcomes, not about the reactivation mechanism. Methylene blue is not an intervention in this review. Study type: review.